Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The pharmaceutical company's stock falls during the session after the announcement this morning of the termination of a Phase 3 clinical study. The st…
Sanofi announced on Wednesday the discontinuation of its Phase 3 MOBILIZE study on riliprubart, a drug candidate for patients with refractory chronic …
The European Commission approved on Monday the subcutaneous formulation of Sarclisa (isatuximab), a treatment for multiple myeloma by Sanofi. This app…
Sanofi and Trackmania are launching a time-limited event partnership on Friday to educate gamers about daily diabetes management. The initiative is pa…
The pharmaceutical company marks the highest increase of the Parisian flagship index while the market trends negatively. The stock is advancing as som…
Sanofi launches on Thursday Action 2026, its global share purchase plan reserved for employees, which is open to approximately 75,000 collaborators ac…
Sanofi announces the integration of Biogen into accelRare, a free pre-diagnostic tool for rare diseases co-developed with 13 Rare Disease Health Netwo…
In the mid-afternoon, the pharmaceutical company is making no progress while the Paris stock market shows significant gains. The stock continues to su…
On Thursday, the FDA granted a priority review for the approval of venglustat to treat type 3 Gaucher's disease in the United States. If approved, thi…
Sanofi shares rise by 1.77% to €76.53 mid-session, as the CAC 40 gains 0.73%. The company is among the top performers on the CAC 40 following the posi…
